NSK–SD™ (Nattokinase)

*Promotes healthy fibrinolytic activity for healthy blood flow  and cardiovascular function

Nattokinase, a fibrinolytic enyzme isolated from Japanese natto,  helps to maintain healthy activity of the body's natural clotting  and fibrinolytic processes. In an animal study conducted by Biotechnology  Research Laboratories and JCR Pharmaceuticals of Kobe, Japan,  nattokinase promoted healthy blood flow. Furthermore, researchers  from JCR Pharmaceuticals, Oklahoma State University and Miyazaki  Medical College indicated that nattokinase supports healthy clotting  function compared to placebo. In 1995, scientists at the Miyazaki  Medical College and Kurashiki University in Japan demonstrated  the potential for nattokinase to support blood vessel health  in human subjects. This product is contraindicated for individuals  with a history of bleeding tendency or with conditions associated  with bleeding. Due to potential synergistic effects